Anti-N-Methyl-D-Aspartate Receptor Encephalitis after BNT162b2 COVID-19 Vaccination

Hyoung Cheol Lee; Byung-Kun Kim; Kyusik Kang; Woong-Woo Lee; Ilhan Yoo; Yong Soo Kim; Jung-Ju Lee

doi:10.14581/jer.22013

Anti-N-Methyl-D-Aspartate Receptor Encephalitis after BNT162b2 COVID-19 Vaccination

J Epilepsy Res. 2022 Dec 30;12(2):71-73. doi: 10.14581/jer.22013. eCollection 2022 Dec.

Authors

Hyoung Cheol Lee¹, Byung-Kun Kim¹, Kyusik Kang¹, Woong-Woo Lee¹, Ilhan Yoo¹, Yong Soo Kim¹, Jung-Ju Lee¹

Affiliation

¹ Department of Neurology, Nowon Eulji Medical Center, Seoul, Korea.

Abstract

After the coronavirus disease 2019 (COVID-19) pandemic emerged, the development of vaccines was accelerated. Neurologic complications of COVID-19 vaccination had been reported, which included encephalitis. In this study, we report a very rare case of a female with anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma that would be triggered by BNT162b2 m-RNA COVID-19 vaccination.

Keywords: COVID19 vaccine; Encephalitis; NMDA.

Publication types

Case Reports